newsfilter
← Latest News
Business Wire·

Surmodics Announces TRANSCEND Trial 36-Month Data to be Presented at 50th Annual VEITH Symposium

Dr. Peter A. Schneider to share trial results during a Nov. 15 session Surmodics, Inc. (NASDAQ:SRDX), a leading provider of medical device and in vitro diagnostic technologies to the health care industry, today